Our Mission
PeopleBeatingCancer supports an evidence-based integrative approach to cancer care. For most newly diagnosed patients, FDA-approved therapies form the foundation of treatment, while evidence-based complementary therapies may help reduce side effects and improve survivorship.
Click the orange button to the right to learn more.
Category Archives for kidney cancer
Time Burden of Kidney Cancer
Time Burden of Kidney Cancer Treatment: What Patients and Survivors Need to Know- Kidney cancer treatment can last months to years with lifelong monitoring. Learn the short- and long-term time burden of
Continue readingFenbendazole and Kidney Cancer
Fenbendazole and Kidney Cancer: What the Research Really Shows– Fenbendazole (fenben), a veterinary anti-parasitic drug, has gained attention in the cancer community as a potential repurposed therapy.
Continue readingKidney Cancer: Need to Know
Kidney Cancer: What Newly Diagnosed Patients and Survivors Need to Know. Kidney cancer—most commonly renal cell carcinoma (RCC)—is one of the more challenging solid tumors because it is often silent
Continue readingKidney Cancer Complementary Therapy-Vitamin D
“In what researchers said is the second study of its kind, it was determined that circulating vitamin D binding protein (DBP) is inversely associated with the risk of kidney cancer.1″ Whether
Continue readingRenal Cell Carcinoma-Resveratrol
“Resveratrol potentiated sorafenib induced inhibitory effect on constitutive STAT3 and STAT5 phosphorylation, apoptotic effects in 786-O cells, and this correlated with down-regulation of various
Continue reading